Community participation needed for “Bras for a Cause”

Translate to Spanish or other 102 languages!

Photo Used for Illustration Purposes. Photo by drazenphoto
- Advertisement -

Every October, DHR Health employees tap into their creativity to participate in the hospital’s annual “Bras for a Cause” fundraiser. This event supports underserved cancer patients throughout the Rio Grande Valley by providing vital resources such as transportation assistance, financial aid, and oncology wigs through the Renaissance Cancer Foundation.

This year, nearly 30 decorated bras were submitted by employees from various departments, showcasing their enthusiasm for raising awareness about breast cancer screenings and mammograms.

“We hold this contest every year as a fun and engaging way for our employees to help promote breast cancer awareness,” said Evelyn Saenz, Executive Director of the Renaissance Cancer Foundation. “We’re always so impressed by the many creative entries we receive.”

- Advertisement -

Community members are encouraged to visit www.dhrhealth.com/brasforacause to view photos of the bra entries and cast their votes by making donations. The bras with the highest donation totals will be declared winners of the fundraiser. Voting is open to the community until October 20, 2024.

All donations to the Renaissance Cancer Foundation are tax-deductible and directly support local cancer patients facing financial challenges during their treatment. For more information about the Renaissance Cancer Foundation or how to get involved, please contact Executive Director Evelyn Saenz at ev.saenz@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -